Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial

BACKGROUND: Liver cirrhosis is commonly accompanied by intestinal dysbiosis and metabolic defects. Many clinical trials have shown microbiota-targeting strategies represent promising interventions for managing cirrhosis and its complications. However, the influences of the intestinal metagenomes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haifeng, Zhu, Xiaofei, Wu, Lingyun, Lou, Xiaobin, Pan, Xiaxia, Liu, Bowen, Zhang, Hua, Zhu, Lingxiao, Li, Lanjuan, Wu, Zhongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170289/
https://www.ncbi.nlm.nih.gov/pubmed/37180228
http://dx.doi.org/10.3389/fmicb.2023.1169811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170289/
https://www.ncbi.nlm.nih.gov/pubmed/37180228
http://dx.doi.org/10.3389/fmicb.2023.1169811

Ejemplares similares